Supply Chain | April 17, 2026
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
Revvity is positioning its technologies as a connected engine for discovery
The company reported net revenue of SEK 13.5 million for the full year 2025
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Subscribe To Our Newsletter & Stay Updated
